Our team combines world class science with industry experience
We are a team of scientists, doctors, healthcare experts, and industry professionals dedicated to win the fight against deadly infectious diseases.
We are the inventors of an antibiotic renewal technology to overcome antibiotic resistant bacteria for many generations to come.
We are also using our platform to develop new combinations of old antimicrobials that we hope can cure the disease known as COVID-19.
Senior Management
Prof Anthony Coates
Founder & Chief Scientific Officer
James Phipson
Interim Chairman and CEO
Dr Yanmin Hu
Director Of Research
Erik van Kaathoven
Chief Financial Officer
Board & Advisors
Dennis Molnar
Non-Executive Director
Patrick Mocatta
Non-Executive Director
Rashmi H Barbhaiya
Chair, Scientific Advisory Committee
Mark J Goldberger
Member, Scientific Advisory Committee
George L Drusano
Member, Scientific Advisory Committee
Dr Thomas Coates
Medical Advisor
Annabel Watson
Investor Relations Advisor
